Stock Chart
AMRN
$11.60
+0.78%
Score:
52.6
STRONG BUY
Pro
Screener
Vol:
0.40x
(vs SPY: 0.3x | vs QQQ: 0.2x)
Volume Ratio Explained
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 22, 2026
Bear Flag
Bearish scenario
quality 62/100
Setup invalidates on a close above $11.7 · pole −16% — no price target (measured-move targets failed our backtest for flags/pennants)
Historically breaks down 69% of the time (n=379) — the only flag with real bearish follow-through. Measured-move targets failed our backtest — none shown.
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and invalidation level are drawn on the chart below.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER
About AMRN - Amarin Corp Plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
Key Statistics
Market Cap
$243M
More AMRN Analysis
This AMRN stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track AMRN's price movements with trendlines, gamma walls, and key support/resistance levels.